secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alaunos Therapeutics, Inc. (TCRT)
CIK:        0001107421
Form:       8-K
Filed at:   2021-11-05T23:59:59+00:00
Accession:  0000950170-21-003235
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Ziopharm director Heidi Hagen resigns, effective November 2, 2021
-----------------------------------------------------------------

- Heidi Hagen resigned from the Board of Directors of Ziopharm Oncology, effective November 2, 2021.
- Resignation was not due to any disagreement with the company.
- No replacement has been announced yet.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1107421/000095017021003235/0000950170-21-003235-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1107421/000095017021003235/ziop-20211105.htm
  HTML page:      https://secwatch.observer/filing/0000950170-21-003235

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer